Virotherapy as a Potential Therapeutic Approach for the Treatment of Aggressive Thyroid Cancer
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Virotherapy as a Potential Therapeutic Approach for the Treatment of Aggressive Thyroid Cancer
Authors
Keywords
-
Journal
Cancers
Volume 11, Issue 10, Pages 1532
Publisher
MDPI AG
Online
2019-10-11
DOI
10.3390/cancers11101532
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Concise Review: Targeting cancer stem cells and their supporting niche using oncolytic viruses
- (2019) Mathieu J.F. Crupi et al. STEM CELLS
- Immune Profiling of Thyroid Carcinomas Suggests the Existence of Two Major Phenotypes: an ATC-like and a PDTC-like
- (2019) Riccardo Giannini et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Induction of cell fusion/apoptosis in anaplastic thyroid carcinoma in orthotopic mouse model by urokinase‐specific oncolytic Sendai virus
- (2019) Yoshihiro Miyagawa et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- Talimogene laherparepvec: review of its mechanism of action and clinical efficacy and safety
- (2019) Steven S Raman et al. Immunotherapy
- Optimizing oncolytic virotherapy in cancer treatment
- (2019) Kevin Harrington et al. NATURE REVIEWS DRUG DISCOVERY
- Recombinant oncolytic Newcastle disease virus displays antitumor activities in anaplastic thyroid cancer cells
- (2018) Ke Jiang et al. BMC CANCER
- CD10 + GPR77 + Cancer-Associated Fibroblasts Promote Cancer Formation and Chemoresistance by Sustaining Cancer Stemness
- (2018) Shicheng Su et al. CELL
- Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018
- (2018) Lorenzo Galluzzi et al. CELL DEATH AND DIFFERENTIATION
- Armed oncolytic viruses: A kick-start for anti-tumor immunity
- (2018) J.F. de Graaf et al. CYTOKINE & GROWTH FACTOR REVIEWS
- The Immune Landscape of Cancer
- (2018) Vésteinn Thorsson et al. IMMUNITY
- Targeted Therapy in Advanced Thyroid Cancer to Resensitize Tumors to Radioactive Iodine
- (2018) Tania Jaber et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Critical Interactions between Immunogenic Cancer Cell Death, Oncolytic Viruses, and the Immune System Define the Rational Design of Combination Immunotherapies
- (2018) Jacob P. van Vloten et al. JOURNAL OF IMMUNOLOGY
- Neoadjuvant BRAF- and Immune-Directed Therapy for Anaplastic Thyroid Carcinoma
- (2018) Maria E. Cabanillas et al. THYROID
- Clinical, pathological and genetic features of anaplastic and poorly differentiated thyroid cancer: A single institute experience
- (2018) Cristina Romei et al. Oncology Letters
- Talimogene laherparepvec: First in class oncolytic virotherapy
- (2018) Robert M. Conry et al. Human Vaccines & Immunotherapeutics
- Oncolytic Immunotherapy for Bladder Cancer Using Coxsackie A21 Virus
- (2018) Nicola E. Annels et al. Molecular Therapy-Oncolytics
- Salvage pembrolizumab added to kinase inhibitor therapy for the treatment of anaplastic thyroid carcinoma
- (2018) Priyanka C. Iyer et al. Journal for ImmunoTherapy of Cancer
- The advent of oncolytic virotherapy in oncology: The Rigvir® story
- (2018) Pēteris Alberts et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Oncolytic Viruses Partner With T-Cell Therapy for Solid Tumor Treatment
- (2018) Amanda Rosewell Shaw et al. Frontiers in Immunology
- Oncolytic adenovirus: A tool for cancer therapy in combination with other therapeutic approaches
- (2018) Nasser Hashemi Goradel et al. JOURNAL OF CELLULAR PHYSIOLOGY
- MEK inhibition enhances oncolytic virus immunotherapy through increased tumor cell killing and T cell activation
- (2018) Praveen K. Bommareddy et al. Science Translational Medicine
- Designing and building oncolytic viruses
- (2017) Justin Maroun et al. Future Virology
- Mutation patterns in genes encoding interferon signaling and antigen presentation: A pan-cancer survey with implications for the use of immune checkpoint inhibitors
- (2017) Jan Budczies et al. GENES CHROMOSOMES & CANCER
- Adenovirotherapy Delivering Cytokine and Checkpoint Inhibitor Augments CAR T Cells against Metastatic Head and Neck Cancer
- (2017) Amanda Rosewell Shaw et al. MOLECULAR THERAPY
- Anaplastic thyroid carcinoma: from clinicopathology to genetics and advanced therapies
- (2017) Eleonora Molinaro et al. Nature Reviews Endocrinology
- Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
- (2017) Jedd D. Wolchok et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rational combination of oncolytic vaccinia virus and PD-L1 blockade works synergistically to enhance therapeutic efficacy
- (2017) Zuqiang Liu et al. Nature Communications
- Targeting the HGF/c-MET pathway: stromal remodelling in pancreatic cancer
- (2017) Srinivasa P. Pothula et al. Oncotarget
- Oncolytic Immunotherapy: Conceptual Evolution, Current Strategies, and Future Perspectives
- (2017) Zong Sheng Guo et al. Frontiers in Immunology
- Myxoma Virus Optimizes Cisplatin for the Treatment of Ovarian Cancer In Vitro and in a Syngeneic Murine Dissemination Model
- (2017) Bernice Nounamo et al. Molecular Therapy-Oncolytics
- Oncolytic Viruses in Cancer Treatment
- (2017) Sean E. Lawler et al. JAMA Oncology
- Oncolytic Viruses—Natural and Genetically Engineered Cancer Immunotherapies
- (2017) Sachin R. Jhawar et al. Frontiers in Oncology
- Combining Oncolytic Adenovirus with Radiation—A Paradigm for the Future of Radiosensitization
- (2017) Sean M. O’Cathail et al. Frontiers in Oncology
- Long-term treatment with the oncolytic ECHO-7 virus Rigvir of a melanoma stage IV M1c patient, a small cell lung cancer stage IIIA patient, and a histiocytic sarcoma stage IV patient-three case reports
- (2016) Pēteris Alberts et al. APMIS
- Tumor-Infiltrating T Cells and the PD-1 Checkpoint Pathway in Advanced Differentiated and Anaplastic Thyroid Cancer
- (2016) Jill J. Bastman et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Deregulation of STING Signaling in Colorectal Carcinoma Constrains DNA Damage Responses and Correlates With Tumorigenesis
- (2016) Tianli Xia et al. Cell Reports
- Treatment of Human Thyroid Carcinoma Cells with the G47delta Oncolytic Herpes Simplex Virus
- (2015) Jia-Ni Wang et al. Asian Pacific Journal of Cancer Prevention
- VEGF-Mediated Induction of PRD1-BF1/Blimp1 Expression Sensitizes Tumor Vasculature to Oncolytic Virus Infection
- (2015) Rozanne Arulanandam et al. CANCER CELL
- Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy
- (2015) Suzanne L. Topalian et al. CANCER CELL
- Integration of PKR-dependent translation inhibition with innate immunity is required for a coordinated anti-viral response
- (2015) Alexandre Dalet et al. FEBS LETTERS
- Anti–PD-1/PD-L1 therapy of human cancer: past, present, and future
- (2015) Lieping Chen et al. JOURNAL OF CLINICAL INVESTIGATION
- Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma
- (2015) Robert H.I. Andtbacka et al. JOURNAL OF CLINICAL ONCOLOGY
- Reciprocal cellular cross-talk within the tumor microenvironment promotes oncolytic virus activity
- (2015) Carolina S Ilkow et al. NATURE MEDICINE
- Oncolytic viruses: a new class of immunotherapy drugs
- (2015) Howard L. Kaufman et al. NATURE REVIEWS DRUG DISCOVERY
- Going viral: a review of replication-selective oncolytic adenoviruses
- (2015) Christopher Larson et al. Oncotarget
- The oncolytic virus dl922-947 reduces IL-8/CXCL8 and MCP-1/CCL2 expression and impairs angiogenesis and macrophage infiltration in anaplastic thyroid carcinoma
- (2015) Carmela Passaro et al. Oncotarget
- Adenovirus Improves the Efficacy of Adoptive T-cell Therapy by Recruiting Immune Cells to and Promoting Their Activity at the Tumor
- (2015) S. Tahtinen et al. Cancer Immunology Research
- Molecular and Translational Classifications of DAMPs in Immunogenic Cell Death
- (2015) Abhishek D. Garg et al. Frontiers in Immunology
- Association of oncolytic adenoviruses with chemotherapies: An overview and future directions
- (2014) Christian Bressy et al. BIOCHEMICAL PHARMACOLOGY
- Indoleamine 2,3-Dioxygenase 1 (IDO1) Is Up-Regulated in Thyroid Carcinoma and Drives the Development of an Immunosuppressant Tumor Microenvironment
- (2014) Sonia Moretti et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- PARP inhibitor olaparib increases the oncolytic activity of dl922-947 in in vitro and in vivo model of anaplastic thyroid carcinoma
- (2014) Carmela Passaro et al. Molecular Oncology
- Copy Number Loss of the Interferon Gene Cluster in Melanomas Is Linked to Reduced T Cell Infiltrate and Poor Patient Prognosis
- (2014) Peter S. Linsley et al. PLoS One
- The control of anaplastic thyroid carcinoma cell lines by oncolytic poxviruses
- (2014) Neil Mundi et al. VIRUS RESEARCH
- Oncolytic Vaccinia Virus Disrupts Tumor-Associated Vasculature in Humans
- (2013) C. J. Breitbach et al. CANCER RESEARCH
- Multimodal immunogenic cancer cell death as a consequence of anticancer cytotoxic treatments
- (2013) H Inoue et al. CELL DEATH AND DIFFERENTIATION
- Ionizing radiation enhances dl922–947-mediated cell death of anaplastic thyroid carcinoma cells
- (2013) Carmela Passaro et al. ENDOCRINE-RELATED CANCER
- Oncolytic viruses as therapeutic cancer vaccines
- (2013) David L Bartlett et al. Molecular Cancer
- Oncolytic Adenovirus With Temozolomide Induces Autophagy and Antitumor Immune Responses in Cancer Patients
- (2013) Ilkka Liikanen et al. MOLECULAR THERAPY
- Oncolytic Virotherapy and Immunogenic Cancer Cell Death: Sharpening the Sword for Improved Cancer Treatment Strategies
- (2013) Samuel T Workenhe et al. MOLECULAR THERAPY
- Immunogenic HSV-mediated Oncolysis Shapes the Antitumor Immune Response and Contributes to Therapeutic Efficacy
- (2013) Samuel T Workenhe et al. MOLECULAR THERAPY
- Preclinical efficacy of the oncolytic measles virus expressing the sodium iodide symporter in iodine non-avid anaplastic thyroid cancer: a novel therapeutic agent allowing noninvasive imaging and radioiodine therapy
- (2012) H V Reddi et al. CANCER GENE THERAPY
- Immune Response Is an Important Aspect of the Antitumor Effect Produced by a CD40L-Encoding Oncolytic Adenovirus
- (2012) I. Diaconu et al. CANCER RESEARCH
- Coxsackievirus B3 Is an Oncolytic Virus with Immunostimulatory Properties That Is Active against Lung Adenocarcinoma
- (2012) S. Miyamoto et al. CANCER RESEARCH
- Infiltration of a mixture of immune cells may be related to good prognosis in patients with differentiated thyroid carcinoma
- (2012) Lucas L. Cunha et al. CLINICAL ENDOCRINOLOGY
- Differentiated thyroid carcinomas may elude the immune system by B7H1 upregulation
- (2012) Lucas Leite Cunha et al. ENDOCRINE-RELATED CANCER
- Inhibition of Autophagy Enhances the Effects of E1A-Defective Oncolytic Adenovirus dl922–947 Against Glioma Cells In Vitro and In Vivo
- (2012) Ginevra Botta et al. HUMAN GENE THERAPY
- Programmed Death-1+T Cells and Regulatory T Cells Are Enriched in Tumor-Involved Lymph Nodes and Associated with Aggressive Features in Papillary Thyroid Cancer
- (2012) Jena D. French et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Oncolytic virotherapy
- (2012) Stephen J Russell et al. NATURE BIOTECHNOLOGY
- High-mobility group box family of proteins: ligand and sensor for innate immunity
- (2012) Hideyuki Yanai et al. TRENDS IN IMMUNOLOGY
- Anaplastic Thyroid Carcinoma
- (2012) Augusto Taccaliti et al. Frontiers in Endocrinology
- An oncolytic adenovirus defective in pRb-binding (dl922–947) can efficiently eliminate pancreatic cancer cells and tumors in vivo in combination with 5-FU or gemcitabine
- (2011) M Bhattacharyya et al. CANCER GENE THERAPY
- The oncolytic adenovirus AdΔΔ enhances selective cancer cell killing in combination with DNA-damaging drugs in pancreatic cancer models
- (2011) G Cherubini et al. GENE THERAPY
- Measles virus causes immunogenic cell death in human melanoma
- (2011) O G Donnelly et al. GENE THERAPY
- Reovirus therapy stimulates endoplasmic reticular stress, NOXA induction and augments bortezomib-mediated apoptosis in multiple myeloma
- (2011) K R Kelly et al. ONCOGENE
- Oncolytic viruses in radiation oncology
- (2011) Yann Touchefeu et al. RADIOTHERAPY AND ONCOLOGY
- Novel therapy for anaplastic thyroid carcinoma cells using an oncolytic vaccinia virus carrying the human sodium iodide symporter
- (2011) Sepideh Gholami et al. SURGERY
- Improved Potency and Selectivity of an Oncolytic E1ACR2 and E1B19K Deleted Adenoviral Mutant in Prostate and Pancreatic Cancers
- (2010) D. Oberg et al. CLINICAL CANCER RESEARCH
- AZD1152 negatively affects the growth of anaplastic thyroid carcinoma cells and enhances the effects of oncolytic virus dl922-947
- (2010) S. Libertini et al. ENDOCRINE-RELATED CANCER
- Antitumoural immunity by virus-mediated immunogenic apoptosis inhibits metastatic growth of hepatocellular carcinoma
- (2010) B. Boozari et al. GUT
- Detailed Molecular Fingerprinting of Four New Anaplastic Thyroid Carcinoma Cell Lines and Their Use for Verification of RhoB as a Molecular Therapeutic Target
- (2010) Laura A. Marlow et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Low-dose paclitaxel synergizes with oncolytic adenoviruses via mitotic slippage and apoptosis in ovarian cancer
- (2010) C K Ingemarsdotter et al. ONCOGENE
- Widespread Phosphorylation of Histone H2AX by Species C Adenovirus Infection Requires Viral DNA Replication
- (2009) G. J. Nichols et al. JOURNAL OF VIROLOGY
- Increased apoptosis and reduced replication efficiency of the E3 region-modified dl309 adenovirus in cancer cells
- (2009) Merilyn H. Hibma et al. VIRUS RESEARCH
- Activation of the Antiviral Kinase PKR and Viral Countermeasures
- (2009) Bianca Dauber et al. Viruses-Basel
- ONYX-411, a conditionally replicative oncolytic adenovirus, induces cell death in anaplastic thyroid carcinoma cell lines and suppresses the growth of xenograft tumors in nude mice
- (2008) H V Reddi et al. CANCER GENE THERAPY
- Bevacizumab Increases Viral Distribution in Human Anaplastic Thyroid Carcinoma Xenografts and Enhances the Effects of E1A-Defective Adenovirus dl922-947
- (2008) S. Libertini et al. CLINICAL CANCER RESEARCH
- Synergy of a Herpes Oncolytic Virus and Paclitaxel for Anaplastic Thyroid Cancer
- (2008) S.-F. Lin et al. CLINICAL CANCER RESEARCH
- Oncolytic Vaccinia Virotherapy of Anaplastic Thyroid Cancerin Vivo
- (2008) Shu-Fu Lin et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Therapeutic potential of statins in thyroid proliferative disease
- (2008) Maurizio Bifulco Nature clinical practice. Endocrinology & metabolism
- Oncolytic virus therapy using genetically engineered herpes simplex viruses
- (2007) Tomoki Todo Frontiers in Bioscience-Landmark
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started